http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10330248-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b55c349b43c3ecba4977fd52cc8f8c67 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
filingDate | 1997-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a433d5aa4d26ba1800765434a4cea57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a43493318a1a56aa34bcfb64576e5fa0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a2e09d6b610dfc1650111e279c9bb62 |
publicationDate | 1998-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H10330248-A |
titleOfInvention | Transdermal preparation and method for producing the same |
abstract | (57) [Problem] To provide a transdermal preparation having excellent adhesive properties and exhibiting good transdermal absorbability. SOLUTION: A crosslinking agent is added to a solution of an acrylic copolymer obtained by copolymerizing an alkyl (meth) acrylate and a functional monomer to partially crosslink the acrylic copolymer. The composition containing the crosslinked acrylic copolymer is pulverized to prepare a pressure-sensitive adhesive solution comprising the acrylic copolymer containing crosslinked acrylic copolymer particles. To this adhesive solution, a drug for percutaneous absorption excluding buprenorphine and / or its salt and a percutaneous absorption enhancer are added to prepare a percutaneous absorption preparation according to the present invention. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6772727-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006513184-A |
priorityDate | 1997-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.